deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT04515004

Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer

Sponsor: VA Office of Research and Development

Conditions Early Stage Lung Cancer (I and II)
Interventions leucoselect phytosome
Updated 18 times since 2020 Last updated: Jan 29, 2026 Started: Nov 20, 2023 Primary completion: Nov 1, 2024 Completion: Mar 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Early termination by sponsor due to substantial delays with subjects recruitment

Other terminated trials from VA Office of Research and Development

See all terminations from VA Office of Research and Development

A PHASE2 clinical study on Early Stage Lung Cancer (I and II), this trial is terminated or withdrawn. The trial is conducted by VA Office of Research and Development and has accumulated 18 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Mar 2022 · 3 months · monthly snapshot~Mar 2022 – ~Jun 2022 · 3 months · monthly snapshot~Jun 2022 – ~Nov 2022 · 5 months · monthly snapshot~Nov 2022 – ~Feb 2023 · 3 months · monthly snapshot~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Sep 2023 · 4 months · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Jul 2025 · 9 months · monthly snapshot~Jul 2025 – ~Feb 2026 · 7 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

18 versions recorded

  1. Feb 2026 — Present [monthly]

    Terminated PHASE2

  2. Jul 2025 — Feb 2026 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

  3. Oct 2024 — Jul 2025 [monthly]

    Recruiting PHASE2

  4. Sep 2024 — Oct 2024 [monthly]

    Recruiting PHASE2

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

▶ Show 13 earlier versions

  1. Oct 2023 — Jul 2024 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  2. Sep 2023 — Oct 2023 [monthly]

    Not Yet Recruiting PHASE2

  3. May 2023 — Sep 2023 [monthly]

    Not Yet Recruiting PHASE2

  4. Apr 2023 — May 2023 [monthly]

    Not Yet Recruiting PHASE2

  5. Feb 2023 — Apr 2023 [monthly]

    Not Yet Recruiting PHASE2

  6. Nov 2022 — Feb 2023 [monthly]

    Not Yet Recruiting PHASE2

  7. Jun 2022 — Nov 2022 [monthly]

    Not Yet Recruiting PHASE2

  8. Mar 2022 — Jun 2022 [monthly]

    Not Yet Recruiting PHASE2

  9. Dec 2021 — Mar 2022 [monthly]

    Not Yet Recruiting PHASE2

  10. Sep 2021 — Dec 2021 [monthly]

    Not Yet Recruiting PHASE2

  11. Feb 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE2

  12. Jan 2021 — Feb 2021 [monthly]

    Not Yet Recruiting PHASE2

  13. Sep 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • VA Office of Research and Development
Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations